NCT04976621

Brief Summary

Depression is common after traumatic brain injury (TBI) and may have wide-ranging consequences. Post-TBI depression may impede reintegration into the family and community and lead to lower quality of life and heightened suicide risk. It may also interfere with rehabilitation. Yet, current treatments for post-TBI depression are based largely on expert opinion rather than evidence from rigorous studies. Behavioral activation (BA) is a promising intervention for post-TBI depression. It is a brief behavioral treatment that helps people define goals, create and execute plans to reach them, and engage in meaningful activities. BA has been tested in clinical trials since the 1970s and has been shown to reduce or prevent depression in populations with diverse medical conditions. However, BA has rarely been used or studied for treatment of depression in a TBI population. The investigators will conduct a study of BA with at least 40 Veterans with TBI and depressive symptoms in VA outpatient rehabilitation care. One group of Veterans will be randomly assigned to receive BA plus usual care. The BA program consists of six sessions delivered over three months at the VA (or Veterans' homes, if preferred) by an occupational therapist (OT). A second group of Veterans will be randomly assigned to receive usual care. The investigators will assess the feasibility of delivering the BA intervention in the rehabilitation setting and its acceptability to Veterans and staff. The research team will also assess participant responses to BA in the outcomes of depressive symptoms, community reintegration, and quality of life. Study findings will be used to guide the development of a future study of BA in a larger sample of Veterans with post-TBI depression. This study and future research may add a powerful clinical tool to rehabilitation services to lessen or prevent depression in Veterans with TBI. Reducing depression may in turn facilitate rehabilitation and enhance community reintegration, allowing Veterans to engage more fully in their families and communities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 1, 2021

Completed
25 days until next milestone

First Posted

Study publicly available on registry

July 26, 2021

Completed
7 months until next milestone

Study Start

First participant enrolled

February 15, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 3, 2024

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

September 22, 2025

Completed
Last Updated

December 12, 2025

Status Verified

November 1, 2025

Enrollment Period

2.2 years

First QC Date

July 1, 2021

Results QC Date

April 28, 2025

Last Update Submit

November 25, 2025

Conditions

Keywords

rehabilitationdepressionveterans

Outcome Measures

Primary Outcomes (1)

  • Depressive Symptom Scores on CES-D

    Depressive symptoms will be measured by The Center for Epidemiologic Studies Depression Scale (CES-D). CES-D is a well-established 20-item screening instrument that shows good psychometric properties in TBI populations. It will be administered at the Baseline interview and Follow-up interview (at 3 months). It uses a Likert-type scale from 0 to 3. The total score is the sum across all 20 items. Total scores may range from 0 to 60, with higher scores indicating greater depressive symptoms.

    3 - 4 months

Secondary Outcomes (2)

  • Community Reintegration Scores on PART-O-17

    3 - 4 months

  • Quality of Life in TBI Scores on QoL-TBI Instrument

    3 - 4 months

Other Outcomes (5)

  • Acceptability of the Intervention Rated by the Interventionist

    3 - 4 months

  • Veteran Acceptability/Satisfaction With the Intervention

    3 - 4 months

  • Recruitment

    16 months

  • +2 more other outcomes

Study Arms (2)

Behavioral Activation (BA) intervention group

EXPERIMENTAL

Participants in the BA group will receive BA treatment and treatment as usual. BA is a brief behavioral treatment that helps people define goals, create and execute plans to attain them, and engage in meaningful activities. The BA intervention will be delivered in 6 sessions over 3 months by Occupational Therapists trained in BA for post-TBI depression. BA sessions will be conducted in person in an office at the VA rehabilitation clinic, virtually by VA Video Connect, or in person in the home, depending on the veteran's preference.

Behavioral: Behavioral ActivationOther: Treatment as Usual

Treatment as Usual Control Group

OTHER

Participants in the Control group receive treatment as usual (TAU), which is usual care provided by the VA medical center.

Other: Treatment as Usual

Interventions

BA is a brief behavioral treatment that helps people define goals, create and execute plans to attain them, and engage in meaningful activities. BA protocol components include: goal setting (especially for activities that promote social connectedness), creation of a plan (broken down into steps), strategies for implementation of steps, identification of potential barriers, tactics to overcome them, activity monitoring and scheduling, and emotion regulation strategies. The BA intervention will be delivered in 6 sessions over 3 months by Occupational Therapists trained in BA for post-TBI depression. BA sessions will be conducted in person in an office at the VA rehabilitation clinic, virtually by VA Video Connect, or in person in the home, depending on the veteran's preference.

Behavioral Activation (BA) intervention group

Treatment as Usual refers to usual care provided by the VA medical center.

Behavioral Activation (BA) intervention groupTreatment as Usual Control Group

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran enrolled in the outpatient Rehabilitation Medicine Service at the Corporal Michael J. Crescenz VA Medical Center
  • Age of 21 years or older
  • Meet professional criteria for mild or moderate TBI
  • Confirmation of TBI diagnosis
  • Have a CES-D score at or above 16 at both the Telephone Screen and Baseline
  • Those taking antidepressants or other medications affecting mood or behavior must have been using these for at least three months, to allow for stabilization.
  • Those in psychotherapy can participate if therapy has been ongoing for three months or longer.
  • Veterans report current TBI-related symptoms on the Telephone Screen.
  • Speak English

You may not qualify if:

  • A diagnosis of severe TBI
  • Psychosis
  • Aphasia
  • History of bipolar disorder
  • Presence of suicidal ideation with affirmative response on item 9 of the PHQ-9
  • History of severe physical aggressiveness, judged by the clinical team
  • Currently receiving Cognitive Behavioral Therapy for depression
  • Dementia (determined on case-by-case basis based on physician diagnosis and participant's difficulty understanding interview questions)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

Philadelphia, Pennsylvania, 19104-4551, United States

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticDepression

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesBehavioral SymptomsBehavior

Results Point of Contact

Title
Helene Moriarty, PhD, RN
Organization
Corporal Michael J. Crescenz VA Medical Center

Study Officials

  • Helene J Moriarty, PhD RN

    Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Care providers at the medical center will not have knowledge of the intervention or control condition assigned to individual participants. The research interviewer at the follow-up interview (the outcome assessor) also has no knowledge of the intervention or control condition assigned to individual participants.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: At the baseline interview, the interviewer will review the study, answer questions, obtain Informed Consent, conduct screening for eligibility, and conduct the baseline interview. The interview will be conducted in the rehabilitation clinic office, by VA Video Connect, or in the home. Veterans who do not wish to continue with the study after the baseline interview will not be randomized. Within 48 hours of the baseline interview, eligible veterans will be randomized using the method of random permuted blocks and concealed allocation. Those randomized to BA will be contacted within 5 days by the interventionist and scheduled for the first session. They will receive the 6-session BA intervention (as well as treatment as usual \[TAU\]). Control participants will receive TAU only (which may include current medical and mental health treatments.) Three months after Baseline, a blinded interviewer will conduct the follow-up interview in person or on the phone with all veterans.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2021

First Posted

July 26, 2021

Study Start

February 15, 2022

Primary Completion

April 16, 2024

Study Completion

June 3, 2024

Last Updated

December 12, 2025

Results First Posted

September 22, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Final data sets underlying all publications resulting from the research will be shared outside VA. A de-identified, anonymized dataset will be created and shared. A final dataset will be made available to the public upon receipt of a study-specific Data Use Agreement made in writing and following IRB and VA R\&D regulations. Data will be provided electronically and per VA regulations for transferring data.

Shared Documents
ANALYTIC CODE
Time Frame
The IDP will be shared starting six months after the publication.
Access Criteria
We will consult with a VA privacy officer and other regulatory specialists at the Corporal Michael Crescenz VA Medical Center, taking all recommended steps to insure that re-identifying participants from the final de-identified and anonymous dataset will not be possible. In addition, the Data Use Agreement will explicitly prohibit attempts to re-identify participants.

Locations